INM · Categories · Form 4
INM - SEC Form 4 insider transactions
InMed Pharmaceuticals Inc. (INM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for INM
- SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Klompas Neil A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Jagpal Netta4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Bathery John Steven4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Klompas Neil A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Jagpal Netta4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Grove Janet P4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by President & CEO Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Baldasare Bryan T4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Director Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- Consultant Mancini Alexandra Diane Janet sold $42 worth of shares (240 units at $0.18), closing all direct ownership in the company (SEC Form 4)4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Tegge Jonathan4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Grove Janet P4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Baldasare Bryan T4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Lemerond Nicole4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Tegge Jonathan4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Li Sarah4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Johnson Shane Aaron4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Woudenberg Michael4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Grove Janet P4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hull Andrew4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Baldasare Bryan T4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Adams Eric A4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Hsu Eric C4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
- SEC Form 4 filed by Mancini Alexandra Diane Janet4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)